Calixar launches new funding round to establish business strategy

March 10, 2020

Calixar aims to become a leader in early drug discovery segment through unique technology and pipeline of novel and high-quality therapeutic targets Funds will enable company to isolate around 100 priority targets for the pharmaceutical industry.

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.